Physician profile
Peter C Mann
NPI 1730179805
$2,820.03
in general payments reported to CMS, 2019-2025
14 companies · $283 in 2025
The $283 reported for 2025 was less than what a typical Urogynecology and Reconstructive Pelvic Surgery (Obstetrics & Gynecology) provider received nationally (typical 2025 total: $413).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,133 · 2021: $290 · 2022: $189 · 2023: $405 · 2024: $521 · 2025: $283.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,209.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,208.77 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $1,095.19 | 2019 | |
| Medtronic, INC. | $529.25 | 2023-2025 | Interstim, Altaviva |
| Boston Scientific Corporation | $478.34 | 2021-2023 | Solyx Sis System |
| Abbvie INC. | $271.46 | 2023-2025 | |
| Astellas Pharma US INC | $177.74 | 2022-2024 | Veozah |
| Escala Medical INC. | $74.00 | 2024 | |
| Davol INC. | $50.23 | 2025 | Arista |
| Meditrina | $31.47 | 2023 | |
| Sumitomo Pharma America, INC. | $21.93 | 2024 | Myfembree |
| Baxter Healthcare | $20.55 | 2025 | Perclot |
| Therapeuticsmd, INC. | $18.79 | 2019 | |
| Ethicon US, LLC | $18.77 | 2019 | |
| Coopersurgical, INC. | $16.29 | 2023 | Summit Doppler |
| Valencia Technologies Corporation | $16.02 | 2025 | Ecoin Device Kit |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Peter Mann listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.